J9311 HCPCS Level II code: Injection, rituximab 10 mg and hyaluronidase
J9311 is the HCPCS code for “Injection, rituximab 10 mg and hyaluronidase” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9311Injection, rituximab 10 mg and hyaluronidase
Short description: Inj rituximab, hyaluronidase
HCPCS · United States
Medicare details
The indicators CMS publishes with J9311 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Jan 1, 2019
Where J9311 sits
- 1J codesDrugs administered other than orally
- 2Active code J9311Injection, rituximab 10 mg and hyaluronidase
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9311 mean?
J9311 is the HCPCS code for “Injection, rituximab 10 mg and hyaluronidase” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9311?
CMS lists J9311’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9311
All J codesJ9305Injection, pemetrexed, not otherwise specified, 10 mgJ9306Injection, pertuzumab, 1 mgJ9307Injection, pralatrexate, 1 mgJ9308Injection, ramucirumab, 5 mgJ9309Injection, polatuzumab vedotin-piiq, 1 mgJ9310Injection, rituximab, 100 mgJ9312Injection, rituximab, 10 mgJ9313Injection, moxetumomab pasudotox-tdfk, 0.01 mgJ9314Injection, pemetrexed (teva), not therapeutically equivalent to j9305, 10 mgJ9315Injection, romidepsin, 1 mgJ9316Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mgJ9317Injection, sacituzumab govitecan-hziy, 2.5 mg